{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:13:15Z","timestamp":1784650395310,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL093093 (STM) andT35 DK065521 (MA)"],"award-info":[{"award-number":["R01 HL093093 (STM) andT35 DK065521 (MA)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL093093 (STM) andT35 DK065521 (MA)"],"award-info":[{"award-number":["R01 HL093093 (STM) andT35 DK065521 (MA)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Serum AMH levels in adult women are part of the diagnostic criteria for polycystic ovary syndrome (PCOS), a condition with marked infertility and metabolic risks. Yet, little is known about AMH levels among women from ethnic minority populations, especially its associations with age and obesity. The objective is to describe the association of age and serum anti-mullerian hormone (AMH) among Samoan women, provide age specific AMH reference levels, and examine the associations of AMH with adiposity and reproductive factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cross-sectional, retrospective study of a representative community-based sample from Samoa was conducted. 670 women with no known reproductive disorders, reproductive surgeries, or hormonal contraceptive use, age 25\u201351 years, were included. Adiposity was assessed by body mass index (BMI) using Polynesian-specific criteria for obesity. Serum AMH was determined by enzyme-linked immunosorbent assay. Serum total testosterone and sex hormone binding globulin were measured, and the free androgen index was calculated. Hormonal contraceptive use, menstrual regularity, and tobacco use were assessed by questionnaire. PCOS prevalence was estimated using current guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Despite a high prevalence of obesity and overweight in Samoan women, serum AMH and its age related decline were similar to those reported in other populations. AMH was negatively associated with age. AMH decline with age in Samoan women is best described by a cubic model. AMH was not associated with BMI or insulin resistance. PCOS prevalence was estimated at 3.4\u20135.1%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study was the first to construct an age specific AMH reference range for Samoan women. PCOS prevalence appears low, supporting other published studies that have demonstrated a complex relationship between adiposity and reproductive health in Samoan women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12958-025-01379-y","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T03:58:02Z","timestamp":1742356682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum anti-mullerian hormone levels and age among Samoan women"],"prefix":"10.1186","volume":"23","author":[{"given":"Grace","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geralyn","family":"Lambert-Messerlian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola L.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulai T.","family":"Fidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Take","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muagututi\u2018a Sefuiva","family":"Reupena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Kershaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinelle B.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Pangburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"McGarvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"1379_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137.","journal-title":"Hum Reprod"},{"key":"1379_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism. 2018;86:33\u201343.","journal-title":"Metabolism"},{"key":"1379_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.fertnstert.2023.01.031","volume":"119","author":"K VanHise","year":"2023","unstructured":"VanHise K, Wang ET, Norris K, Azziz R, Pisarska MD, Chan JL. Racial and ethnic disparities in polycystic ovary syndrome. Fertil Steril. 2023;119:348\u201354.","journal-title":"Fertil Steril"},{"key":"1379_CR4","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/life12121974","volume":"12","author":"A Yasmin","year":"2022","unstructured":"Yasmin A, Roychoudhury S, Paul Choudhury A, Ahmed ABF, Dutta S, Mottola F, Verma V, Kalita JC, Kumar D, Sengupta P, et al. Polycystic ovary syndrome: an updated overview foregrounding impacts of ethnicities and geographic variations. Life. 2022;12:1974.","journal-title":"Life"},{"key":"1379_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman M, Boyle LA. Recommendations from the 2023 international Evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023;120:767\u201393.","journal-title":"Fertil Steril"},{"key":"1379_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.fertnstert.2013.09.015","volume":"101","author":"ME Bleil","year":"2014","unstructured":"Bleil ME, Gregorich SE, Adler NE, Sternfeld B, Rosen MP, Cedars MI. Race\/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four Race\/ethnic groups of healthy, regularly cycling women. Fertil Steril. 2014;101:199\u2013207.","journal-title":"Fertil Steril"},{"key":"1379_CR7","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.fertnstert.2008.08.110","volume":"92","author":"DB Seifer","year":"2009","unstructured":"Seifer DB, Golub ET, Lambert-Messerlian G, Benning L, Anastos K, Watts DH, Cohen MH, Karim R, Young MA, Minkoff H, et al. Variations in serum m\u00fcllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril. 2009;92:1674\u20138.","journal-title":"Fertil Steril"},{"key":"1379_CR8","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1210\/jc.2012-3995","volume":"98","author":"M D\u00f3lleman","year":"2013","unstructured":"D\u00f3lleman M, Verschuren WMM, Eijkemans MJC, Doll\u00e9 MET, Jansen EHJM, Broekmans FJM, Van Der Schouw YT. Reproductive and lifestyle determinants of Anti-M\u00fcllerian hormone in a large Population-based study. J Clin Endocrinol Metabolism. 2013;98:2106\u201315.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1379_CR9","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/humrep\/deq071","volume":"25","author":"MH Van Den Berg","year":"2010","unstructured":"Van Den Berg MH, Van Dulmen-den Broeder E, Overbeek A, Twisk JWR, Schats R, Van Leeuwen FE, Kaspers GJ, Lambalk CB. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. Hum Reprod. 2010;25:1520\u20137.","journal-title":"Hum Reprod"},{"key":"1379_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejogrb.2012.04.013","volume":"163","author":"A La Marca","year":"2012","unstructured":"La Marca A, Spada E, Grisendi V, Argento C, Papaleo E, Milani S, Volpe A. Normal serum anti-M\u00fcllerian hormone levels in the general female population and the relationship with reproductive history. Eur J Obstet Gynecol Reproductive Biology. 2012;163:180\u20134.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"key":"1379_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/humupd\/dmae004","volume":"30","author":"L Werner","year":"2024","unstructured":"Werner L, Van Der Schouw YT, De Kat AC. A systematic review of the association between modifiable lifestyle factors and Circulating anti-M\u00fcllerian hormone. Hum Reprod Update. 2024;30:262\u2013308.","journal-title":"Hum Reprod Update"},{"key":"1379_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ajhb.22553","volume":"26","author":"NL Hawley","year":"2014","unstructured":"Hawley NL, Minster RL, Weeks DE, Viali S, Reupena MS, Sun G, Cheng H, Deka R, McGarvey ST. Prevalence of adiposity and associated cardiometabolic risk factors in the Samoan genome-wide association study. Am J Hum Biol. 2014;26:491\u2013501.","journal-title":"Am J Hum Biol"},{"key":"1379_CR13","doi-asserted-by":"publisher","first-page":"e23106","DOI":"10.1002\/ajhb.23106","volume":"30","author":"H Maredia","year":"2018","unstructured":"Maredia H, Hawley NL, Lambert-Messerlian G, Fidow U, Reupena MS, Naseri T, McGarvey ST. Reproductive health, obesity, and cardiometabolic risk factors among Samoan women. Am J Hum Biol. 2018;30:e23106.","journal-title":"Am J Hum Biol"},{"key":"1379_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1210\/jc.2007-1834","volume":"93","author":"BO Yildiz","year":"2008","unstructured":"Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metabolism. 2008;93:162\u20138.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1379_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/humrep\/deu036","volume":"29","author":"P Welsh","year":"2014","unstructured":"Welsh P, Smith K, Nelson SM. A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay. Hum Reprod. 2014;29:1035\u201341.","journal-title":"Hum Reprod"},{"key":"1379_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cca.2015.08.019","volume":"450","author":"HN Bui","year":"2015","unstructured":"Bui HN, Sluss PM, Hayes FJ, Blincko S, Knol DL, Blankenstein MA, Heijboer AC. Testosterone, free testosterone, and free androgen index in women: reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome. Clin Chim Acta. 2015;450:227\u201332.","journal-title":"Clin Chim Acta"},{"key":"1379_CR17","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.clinbiochem.2016.02.006","volume":"49","author":"H Maredia","year":"2016","unstructured":"Maredia H, Lambert-Messerlian GM, Palomaki GE, Viali S, Hawley NL, McGarvey ST. Cutoff levels for hyperandrogenemia among Samoan women: an improved methodology for deriving normative data in an obese population. Clin Biochem. 2016;49:782\u20136.","journal-title":"Clin Biochem"},{"key":"1379_CR18","doi-asserted-by":"crossref","unstructured":"Adia AC, Hawley NL, Naseri T, Reupena MS, McGarvey ST. Tobacco smoking patterns in Samoa in 2010: implications for interventions. Tob Prev Cessat. 2019;5.","DOI":"10.18332\/tpc\/114093"},{"key":"1379_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u00df-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"1379_CR20","doi-asserted-by":"crossref","unstructured":"Qu H-Q, Li Q, Rentfro AR, Fisher-Hoch SP, McCormick JB. The Definition of Insulin Resistance Using HOMA-IR for Americans of Mexican Descent Using Machine Learning. Vella A, editor. PLoS ONE. 2011;6:e21041.","DOI":"10.1371\/journal.pone.0021041"},{"key":"1379_CR21","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1093\/humrep\/der095","volume":"26","author":"G Lambert-Messerlian","year":"2011","unstructured":"Lambert-Messerlian G, Roberts MB, Urlacher SS, Ah-Ching J, Viali S, Urbanek M, McGarvey ST. First assessment of menstrual cycle function and reproductive endocrine status in Samoan women. Hum Reprod. 2011;26:2518\u201324.","journal-title":"Hum Reprod"},{"key":"1379_CR22","unstructured":"Croghan W, Egeghy PP. Methods of dealing with values below the limit of detection using SAS carry. In: 2003."},{"key":"1379_CR23","unstructured":"R: The R Project for Statistical Computing."},{"key":"1379_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.fertnstert.2024.05.163","volume":"122","author":"K van der Ham","year":"2024","unstructured":"van der Ham K, Laven JSE, Tay CT, Mousa A, Teede H, Louwers YV. Anti-m\u00fcllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis. Fertil Steril. 2024;122:727\u201339.","journal-title":"Fertil Steril"},{"key":"1379_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.fertnstert.2024.07.002","volume":"122","author":"DB Seifer","year":"2024","unstructured":"Seifer DB. Elevated antim\u00fcllerian hormone level is useful in making the diagnosis of polycystic ovarian morphology and likely one day the diagnosis of polycystic ovary syndrome. Fertil Steril. 2024;122:633\u20134.","journal-title":"Fertil Steril"},{"key":"1379_CR26","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/humrep\/dex226","volume":"32","author":"S Lie Fong","year":"2017","unstructured":"Lie Fong S, Laven JSE, Duhamel A, Dewailly D. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-M\u00fcllerian hormone using cluster analysis. Hum Reprod. 2017;32:1723\u2013173.","journal-title":"Hum Reprod"},{"key":"1379_CR27","doi-asserted-by":"publisher","first-page":"049","DOI":"10.1055\/s-0044-1786731","volume":"42","author":"TT Piltonen","year":"2024","unstructured":"Piltonen TT, Viita-aho J, Saarela U, Melin J, Forslund M. Utility of serum Anti-M\u00fcllerian hormone measurement as part of polycystic ovary syndrome diagnosis. Semin Reprod Med. 2024;42:049\u201359.","journal-title":"Semin Reprod Med"},{"key":"1379_CR28","doi-asserted-by":"crossref","unstructured":"Barbagallo F, Van Der Ham K, Willemsen SP, Louwers YV, Laven JS. Age-related curves of AMH using the gen II, the PicoAMH, and the Elecsys assays in women with polycystic ovary syndrome. J Clin Endocrinol Metabolism. 2024:dgae153.","DOI":"10.1210\/clinem\/dgae153"},{"key":"1379_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12958-015-0134-9","volume":"13","author":"A Dumont","year":"2015","unstructured":"Dumont A, Robin G, Catteau-Jonard S, Dewailly D. Role of Anti-M\u00fcllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod Biol Endocrinol. 2015;13:137.","journal-title":"Reprod Biol Endocrinol"},{"key":"1379_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12958-023-01064-y","volume":"21","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu X, Xu X, Li J, Bu Z, Yang Q, Shi H, Niu W, Dai S, Liang Y, et al. The reference value of anti-M\u00fcllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study. Reprod Biol Endocrinol. 2023;21:15.","journal-title":"Reprod Biol Endocrinol"},{"key":"1379_CR31","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1210\/clinem\/dgaa436","volume":"105","author":"EG Jaswa","year":"2020","unstructured":"Jaswa EG, Rios JS, Cedars MI, Santoro NF, Pavone MEG, Legro RS, Huddleston HG. Increased body mass index is associated with a nondilutional reduction in antim\u00fcllerian hormone. J Clin Endocrinol Metabolism. 2020;105:3234\u201342.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1379_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.rbmo.2017.05.013","volume":"35","author":"T Lefebvre","year":"2017","unstructured":"Lefebvre T, Dumont A, Pigny P, Dewailly D. Effect of obesity and its related metabolic factors on serum anti-M\u00fcllerian hormone concentrations in women with and without polycystic ovaries. Reprod Biomed Online. 2017;35:325\u201330.","journal-title":"Reprod Biomed Online"},{"key":"1379_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106:6\u201315.","journal-title":"Fertil Steril"},{"key":"1379_CR34","doi-asserted-by":"publisher","first-page":"96351","DOI":"10.18632\/oncotarget.19180","volume":"8","author":"T Ding","year":"2017","unstructured":"Ding T, Hardiman PJ, Petersen I, Wang F-F, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8:96351\u20138.","journal-title":"Oncotarget"},{"key":"1379_CR35","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijerph15112589","volume":"15","author":"WM Wolf","year":"2018","unstructured":"Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity. IJERPH. 2018;15:2589.","journal-title":"IJERPH"},{"key":"1379_CR36","doi-asserted-by":"crossref","unstructured":"Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WHB. A Validated Model of Serum Anti-M\u00fcllerian Hormone from Conception to Menopause. Vitzthum VJ, editor. PLoS ONE. 2011;6:e22024.","DOI":"10.1371\/journal.pone.0022024"},{"key":"1379_CR37","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division. (2022). World Population Prospects 2022, Online Edition. https:\/\/population.un.org\/wpp\/downloads?folder=Standard%20Projections&group=Fertility"},{"key":"1379_CR38","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ng.3620","volume":"48","author":"RL Minster","year":"2016","unstructured":"Minster RL, Hawley NL, Su C-T, Sun G, Kershaw EE, Cheng H, Buhule OD, Lin J, Reupena MS, Viali S, et al. A thrifty variant in CREBRF strongly influences body mass index in Samoans. Nat Genet. 2016;48:1049\u201354.","journal-title":"Nat Genet"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01379-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01379-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01379-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:54:44Z","timestamp":1757145284000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01379-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01379-y","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Brown University Institutional Review Board and the Health Research Committee of the Samoan Ministry of Health approved the 2010 GWAS and the Samoan language written consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}